Who Paid My Doc
Heidi Hansen
Dentist, Oral Medicine Portland, OR Doctor of Dentistry
NPI 1063655967 CMS profile 422113
4805 Ne Glisan St Ste 11N, Portland, OR 97213
General payments
$125
Research payments
$0
Ownership & investment interest
$0
Through program year 2022, Heidi Hansen of Portland, OR is reported in the CMS Open Payments database as having received $125 across 1 general payment and $0 in research payments paid to them.
No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.
By program year
1 row| Year | Kind | Relative to this record's peak year | Amount | Records |
|---|---|---|---|---|
| 2022 | General | $125 | 1 |
Beside peers
- Heidi Hansen
- Oregon median
- Middle half of Oregon
- National median
In program year 2025, general payments to Heidi Hansen were reported at $0. Among 8,828 Oregon profiles paid that year, the median was $125 and the middle half received between $38 and $384.
Show as a table
| Year | Heidi Hansen | Oregon median | Middle half | National median |
|---|---|---|---|---|
| 2019 | $0 | $117 | $35–$433 | $163 |
| 2020 | $0 | $82 | $25–$259 | $114 |
| 2021 | $0 | $91 | $27–$282 | $132 |
| 2022 | $125 | $111 | $35–$326 | $149 |
| 2023 | $0 | $120 | $38–$359 | $160 |
| 2024 | $0 | $124 | $39–$382 | $164 |
| 2025 | $0 | $125 | $38–$384 | $169 |
Breakdown
A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.
Prescribing to Medicare patients
Part D · data year 2024 · 9 drugsPart D claims
432
Drug cost
$9,700
Branded share of claims
19.7%
| Drug | Type | Relative to their largest | Claims | Drug cost |
|---|---|---|---|---|
| Clobetasol Propionate | Generic | 35 | $1,822 | |
| Pentoxifylline | Generic | 78 | $1,678 | |
| Clotrimazole | Generic | 54 | $1,472 | |
| Dexamethasone | Generic | 48 | $1,367 | |
| Doxycycline Hyclate | Generic | 67 | $1,166 | |
| Amoxicillin-Clavulanate Potass Amoxicillin/Potassium Clav | Brand | 17 | $1,039 | |
| Clinpro 5000 Fluoride (Sodium) | Brand | 39 | $582 | |
| Sodium Fluoride Fluoride (Sodium) | Brand | 29 | $334 | |
| Chlorhexidine Gluconate | Generic | 65 | $241 |
Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 138 Part D prescribers listed as Undefined Physician type; they describe a distribution and say nothing about conduct.
Billing to Medicare
Part B · data year 2024 · 18 billing codesPaid by Medicare
$20,252
Medicare patients
124
Services billed
355
| Condition among their Medicare patients | Relative to the most common | Share of patients |
|---|---|---|
| High blood pressure | 63% | |
| Arthritis | 39% | |
| Cancer | 35% | |
| Diabetes | 25% | |
| Depression | 25% | |
| Osteoporosis | 23% | |
| Atrial fibrillation | 19% | |
| Heart failure | 17% |
Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.
Records
1 reportedEvery payment, record by record
Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.
Related records
Dentist, Oral Medicine in Oregon
Practitioners in the same specialty and state, ranked by reported value.
All Dentist, Oral Medicine
Everyone recorded under this specialty, nationwide.
Doctors in Oregon
Every practitioner in the state with a reported payment.
How to read this page
What each amount means, and what it does not mean.
What this means
U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.
An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.
Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.